The severe fatty liver observed in SGLT5-deficient mice was also associated with increased plasma ALT and AST, which are commonly used parameters reflecting hepatic impairment, including NAFLD (Table 1) [33]. The gene discussed is SLC5A10; the disease is metabolic dysfunction-associated steatotic liver disease.